1AD Ann: AD-214 well tolerated in Phase I extension study - 23rd Oct 2023, 8:20am

annb0t

annb0t

Top 20
1AD Ann: AD-214 well tolerated in Phase I extension study
Price Sensitive: Y
Date: 23rd Oct 2023, 8:20am

>>> Read announcement: Google: 1AD Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
1AD Ann: AD-214 oral presentation at MPGPCR23 - 19th Oct 2023, 8:18am
Replies
0
Views
87
annb0t
annb0t
annb0t
1AD Ann: Prof Foley invited presentation AD-214 - 26th Sep 2023, 8:19am
Replies
0
Views
173
annb0t
annb0t
annb0t
1AD Ann: Dosing simulations support AD-214 IV product profile - 25th Sep 2023, 8:20am
Replies
0
Views
70
annb0t
annb0t
annb0t
1AD Ann: AD-214 Phase I extension study fully enrolled - 20th Sep 2023, 8:18am
Replies
0
Views
96
annb0t
annb0t
annb0t
1AD Ann: Investor webinar - recent AD-214 progress - 7th Aug 2023, 9:05am
Replies
0
Views
108
annb0t
annb0t
Top Bottom